Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China · Delayed Price · Currency is CNY 5.25
-0.18 (-3.31%)
Jun 8, 2026, 3:04 PM CST
SHE:300639 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,295 | 3,377 | 3,772 | 5,990 | 7,361 | 8,595 | |
Market Cap Growth | -1.40% | -10.48% | -37.03% | -18.63% | -14.35% | -2.84% |
Enterprise Value | 2,345 | 2,432 | 3,054 | 5,316 | 6,815 | 7,868 |
Last Close Price | 5.25 | 5.38 | 5.93 | 9.24 | 10.84 | 12.52 |
PE Ratio | - | - | - | 42.64 | 4.26 | 10.09 |
Forward PE | - | 18.89 | 24.20 | 23.95 | 4.88 | 12.96 |
PS Ratio | 4.98 | 5.04 | 4.63 | 5.42 | 1.32 | 3.22 |
PB Ratio | 0.89 | 0.92 | 0.93 | 1.18 | 1.41 | 2.47 |
P/TBV Ratio | 0.93 | 0.97 | 0.98 | 1.30 | 1.56 | 2.78 |
P/FCF Ratio | 14.64 | 13.55 | - | - | 12.81 | - |
P/OCF Ratio | 10.31 | 9.88 | 47.88 | 18.74 | 5.62 | 13.61 |
EV/Sales Ratio | 3.55 | 3.63 | 3.75 | 4.81 | 1.22 | 2.94 |
EV/EBITDA Ratio | - | - | - | 33.24 | 2.63 | 6.98 |
EV/EBIT Ratio | - | - | - | - | 2.81 | 7.52 |
EV/FCF Ratio | 10.42 | 9.76 | - | - | 11.86 | - |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 |
Debt / EBITDA Ratio | - | - | - | 0.33 | 0.05 | 0.16 |
Debt / FCF Ratio | 0.39 | 0.36 | - | - | 0.24 | - |
Net Debt / Equity Ratio | -0.23 | -0.26 | -0.22 | -0.20 | -0.24 | -0.29 |
Net Debt / EBITDA Ratio | 38.20 | 25.71 | 1.35 | -6.35 | -0.49 | -0.90 |
Net Debt / FCF Ratio | -3.84 | -3.81 | 12.59 | 15.45 | -2.21 | 104.21 |
Asset Turnover | 0.15 | 0.15 | 0.16 | 0.18 | 1.02 | 0.75 |
Inventory Turnover | 5.29 | 5.92 | 5.33 | 4.05 | 13.59 | 7.11 |
Quick Ratio | 4.85 | 4.98 | 4.70 | 5.86 | 3.05 | 3.44 |
Current Ratio | 5.30 | 5.38 | 5.04 | 6.26 | 3.23 | 3.77 |
Return on Equity (ROE) | -3.77% | -4.73% | -20.78% | 1.33% | 41.41% | 29.45% |
Return on Assets (ROA) | -2.45% | -2.69% | -9.79% | -0.06% | 27.61% | 18.44% |
Return on Invested Capital (ROIC) | -6.17% | -6.40% | -22.34% | -0.14% | 63.97% | 45.84% |
Return on Capital Employed (ROCE) | -4.40% | -5.00% | -19.40% | -0.10% | 45.10% | 29.40% |
Earnings Yield | -3.23% | -3.88% | -17.36% | 2.34% | 23.45% | 9.92% |
FCF Yield | 6.83% | 7.38% | -1.84% | -1.10% | 7.81% | -0.11% |
Dividend Yield | - | - | - | 0.70% | 2.15% | 1.24% |
Payout Ratio | - | - | - | 114.22% | 6.62% | 8.93% |
Buyback Yield / Dilution | -0.00% | 2.88% | - | - | 0.02% | -7.39% |
Total Shareholder Return | -0.00% | 2.88% | - | 0.70% | 2.17% | -6.15% |